Rimeholt found early metabolic drift in a group of Traverse Tier members and was able to reverse it inside seven months:

Translating to a measurable drop in ten-year risk of heart attack, stroke, or fatal cardiac events¹

31%

Drop in ApoB

The main carrier of plaque-forming lipids

7%

Reversal of insulin resistance

A leading driver of metabolic strain

54%

¹Modelled reduction in ten-year risk of major adverse cardiac events across the 1,182-member cohort.